The New Approach to Early Diagnosis of Adenomyosis

October 2010 in “ Reproductive Biomedicine Online ”

Anastasia Sorokina, V.E. Radzinsky

Studysummary A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

Read the full study on rbmojournal.com →

Discuss this study in the Community →

Similar research 5

Detection of Circulating Prostate Cancer Cells by Means of an Antibody-Conjugated Nanoparticulate Biosensor European Urology Supplements · 2011
Androgen- and Estrogen-Secreting Adrenal Cancers Seminars in Oncology · 2010
SAT-080: An Atypical Adenoma Presenting with Hyperandrogenism - A Rare Case of Pituitary Germ Cell Tumor Journal of the Endocrine Society · 2025
Editorial Comment Urology · 2013
Rare Presentation of Precocious Puberty Secondary to LH-Secreting Adenoma Journal of the Endocrine Society · 2022

Related Community Posts Join

6 / 1000+ results

community New angles to attack beyond DHT

4 upvotes 2 years ago

Exploring hair loss treatments beyond DHT, including Minoxidil, pyruvate, Gt20029 targeting androgen receptors, and vasodilators. Other options like Kx826, adenosine signaling, growth factor topicals, and microneedling are also discussed.

community Interesting new publication suggesting that MPB should be assessed as a early warning sign for type-2 diabetes.

15 upvotes 8 years ago

Male pattern baldness (MPB) may be an early warning sign for type 2 diabetes due to its association with insulin resistance. Treatments discussed include testosterone therapy and finasteride, which affects hormone levels related to hair loss and insulin sensitivity.

community Pp405 trials question - 2a/2b,

6 upvotes 11 months ago

PP405 trials have completed phase 2a, showing promising results with a 31% stat for hair density increase, and are moving directly to phase 3. Detailed results will be presented at a medical conference in 2026.

community Pp405 phase 2a clinical results

37 upvotes 1 year ago

PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.

community Pp405 AAD presentation tomorrow - fingers crossed - what to expect?

in Research/Science 84 upvotes 5 months ago

New hair loss treatments PP405 and VDPHL01 are discussed with skepticism and hope, alongside existing treatments like minoxidil and finasteride. Users express frustration over limited progress since the 1980s but remain cautiously optimistic.

community AGA evaluation and first steps - BEGINNER MEGAPOST

80 upvotes 2 years ago

The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.